ArticleJournal of autoimmunity2018

A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.

Laurence B Peterson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.